Benjamin Edwards Inc 10x Genomics, Inc. Transaction History

Benjamin Edwards Inc

  • $6.91 Billion
  • Q1 2025

A detailed history of Benjamin Edwards Inc transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Benjamin Edwards Inc holds 77,155 shares of TXG stock, worth $735,287. This represents 0.01% of its overall portfolio holdings.

Number of Shares
77,155
Previous 69,926 10.34%
Holding current value
$735,287
Previous $1 Million 32.97%
% of portfolio
0.01%
Previous 0.01%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 12, 2025
BUY
$8.73 - $16.31 $63,109 - $117,904
7,229 Added 10.34%
77,155 $673,000
Q4 2024

Feb 14, 2025
BUY
$13.18 - $21.31 $153,731 - $248,559
11,664 Added 20.02%
69,926 $1 Million
Q3 2024

Nov 14, 2024
BUY
$15.71 - $23.49 $910,363 - $1.36 Million
57,948 Added 18454.78%
58,262 $1.32 Million
Q2 2024

Aug 12, 2024
BUY
$19.45 - $37.37 $739 - $1,420
38 Added 13.77%
314 $6,000
Q1 2024

Apr 29, 2024
BUY
$36.08 - $54.3 $4,762 - $7,167
132 Added 91.67%
276 $10,000
Q4 2023

Feb 06, 2024
SELL
$34.32 - $57.55 $1,750 - $2,935
-51 Reduced 26.15%
144 $8,000
Q2 2023

Aug 15, 2023
SELL
$50.96 - $58.72 $3,363 - $3,875
-66 Reduced 25.29%
195 $11,000
Q1 2023

Apr 27, 2023
BUY
$35.33 - $55.79 $1,236 - $1,952
35 Added 15.49%
261 $15,000
Q4 2022

Feb 07, 2023
BUY
$24.4 - $41.3 $1,415 - $2,395
58 Added 34.52%
226 $8,000
Q3 2022

Oct 28, 2022
SELL
$28.48 - $52.59 $113 - $210
-4 Reduced 2.33%
168 $5,000
Q2 2022

Aug 12, 2022
BUY
$36.95 - $82.41 $332 - $741
9 Added 5.52%
172 $8,000
Q1 2022

May 04, 2022
BUY
$55.7 - $145.79 $222 - $583
4 Added 2.52%
163 $12,000
Q4 2021

Feb 07, 2022
SELL
$135.05 - $182.59 $810 - $1,095
-6 Reduced 3.64%
159 $24,000
Q3 2021

Nov 02, 2021
SELL
$145.58 - $192.14 $3,202 - $4,227
-22 Reduced 11.76%
165 $24,000
Q2 2021

Aug 11, 2021
BUY
$134.22 - $202.37 $3,758 - $5,666
28 Added 17.61%
187 $37,000
Q1 2021

May 14, 2021
BUY
$140.25 - $196.86 $22,299 - $31,300
159 New
159 $29,000

Others Institutions Holding TXG

# of Institutions
304
Shares Held
109M
Call Options Held
228K
Put Options Held
157K
View Full List

About 10x Genomics, Inc.

TXG Quotes by TradingView
  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $906M
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Benjamin Edwards Inc Portfolio

Follow Benjamin Edwards Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Benjamin Edwards Inc, based on Form 13F filings with the SEC.

News

Stay updated on Benjamin Edwards Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email